Position in GRAL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$33,979,600
New position
Shares Held
657,500
first reported quarter
Ownership
1.53%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in GRAL
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$33,592,000
PutShares
650,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Jefferies Financial Group Inc. holds $132,984,184 across 14 Diagnostics & Research names. GRAL ranks #2 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
218,675 | $37,292,834 | |
| 2 | GRAL |
GRAIL, Inc.
This page
|
657,500 | $33,979,600 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
54,886 | $26,978,115 | |
| 4 | A |
Agilent Technologies, Inc.
|
138,826 | $15,823,387 | |
| 5 | DGX |
Quest Diagnostics Inc
|
33,473 | $6,560,038 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,600 | $2,828,186 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
1,693 | $2,135,211 | |
| 8 | GH |
Guardant Health, Inc.
|
18,879 | $1,743,853 |
All Filings in GRAL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,592,000 | 650,000 | Put | Defined | 2026-05-08 | |
| 2026-03-31 | $33,979,600 | 657,500 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||